Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection

Makoto Inoue, Kayoko Takeda, Kunihiko Morita, Masakazu Yamada, Yusuke Tanigawara, Yoshihisa Oguchi

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

To compare vitreous concentrations of triamcinolone acetonide (TA) achieved by prior therapeutic intravitreal and subtenon injections. Interventional case series. Vitreous samples were collected from patients who required vitreous surgery, six having received a subtenon injection of TA and another six, an intravitreal injection. Vitreous concentrations of TA were measured by high-performance liquid chromatography. Vitreous concentrations of TA after intravitreal injection were 1.22 ± 0.24 μg/ml, significantly higher than those after subtenon injection (<0.001 μg/ml, P =. 003). Vitreous concentrations of TA after subtenon injection and TA-assisted vitrectomy performed in a few patients to visualize the transparent vitreous gel were 0.20 ± 0.11 μg/ml, an intermediate amount between these two groups. Much higher vitreous concentrations of TA after intravitreal injection than subtenon injection may accelerate therapeutic effect when intravitreal injections are given to reduce macular edema. Subtenon injections of TA may act via the sclera as opposed to the vitreous.

Original languageEnglish
Pages (from-to)1046-1048
Number of pages3
JournalAmerican Journal of Ophthalmology
Volume138
Issue number6
DOIs
Publication statusPublished - 2004 Dec

Fingerprint

Triamcinolone Acetonide
Intravitreal Injections
Injections
Sclera
Macular Edema
Vitrectomy
Therapeutic Uses
Gels
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. / Inoue, Makoto; Takeda, Kayoko; Morita, Kunihiko; Yamada, Masakazu; Tanigawara, Yusuke; Oguchi, Yoshihisa.

In: American Journal of Ophthalmology, Vol. 138, No. 6, 12.2004, p. 1046-1048.

Research output: Contribution to journalArticle

Inoue, Makoto ; Takeda, Kayoko ; Morita, Kunihiko ; Yamada, Masakazu ; Tanigawara, Yusuke ; Oguchi, Yoshihisa. / Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. In: American Journal of Ophthalmology. 2004 ; Vol. 138, No. 6. pp. 1046-1048.
@article{4319aa4ef34c45cab7fd162e82ea0fc3,
title = "Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection",
abstract = "To compare vitreous concentrations of triamcinolone acetonide (TA) achieved by prior therapeutic intravitreal and subtenon injections. Interventional case series. Vitreous samples were collected from patients who required vitreous surgery, six having received a subtenon injection of TA and another six, an intravitreal injection. Vitreous concentrations of TA were measured by high-performance liquid chromatography. Vitreous concentrations of TA after intravitreal injection were 1.22 ± 0.24 μg/ml, significantly higher than those after subtenon injection (<0.001 μg/ml, P =. 003). Vitreous concentrations of TA after subtenon injection and TA-assisted vitrectomy performed in a few patients to visualize the transparent vitreous gel were 0.20 ± 0.11 μg/ml, an intermediate amount between these two groups. Much higher vitreous concentrations of TA after intravitreal injection than subtenon injection may accelerate therapeutic effect when intravitreal injections are given to reduce macular edema. Subtenon injections of TA may act via the sclera as opposed to the vitreous.",
author = "Makoto Inoue and Kayoko Takeda and Kunihiko Morita and Masakazu Yamada and Yusuke Tanigawara and Yoshihisa Oguchi",
year = "2004",
month = "12",
doi = "10.1016/j.ajo.2004.05.028",
language = "English",
volume = "138",
pages = "1046--1048",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection

AU - Inoue, Makoto

AU - Takeda, Kayoko

AU - Morita, Kunihiko

AU - Yamada, Masakazu

AU - Tanigawara, Yusuke

AU - Oguchi, Yoshihisa

PY - 2004/12

Y1 - 2004/12

N2 - To compare vitreous concentrations of triamcinolone acetonide (TA) achieved by prior therapeutic intravitreal and subtenon injections. Interventional case series. Vitreous samples were collected from patients who required vitreous surgery, six having received a subtenon injection of TA and another six, an intravitreal injection. Vitreous concentrations of TA were measured by high-performance liquid chromatography. Vitreous concentrations of TA after intravitreal injection were 1.22 ± 0.24 μg/ml, significantly higher than those after subtenon injection (<0.001 μg/ml, P =. 003). Vitreous concentrations of TA after subtenon injection and TA-assisted vitrectomy performed in a few patients to visualize the transparent vitreous gel were 0.20 ± 0.11 μg/ml, an intermediate amount between these two groups. Much higher vitreous concentrations of TA after intravitreal injection than subtenon injection may accelerate therapeutic effect when intravitreal injections are given to reduce macular edema. Subtenon injections of TA may act via the sclera as opposed to the vitreous.

AB - To compare vitreous concentrations of triamcinolone acetonide (TA) achieved by prior therapeutic intravitreal and subtenon injections. Interventional case series. Vitreous samples were collected from patients who required vitreous surgery, six having received a subtenon injection of TA and another six, an intravitreal injection. Vitreous concentrations of TA were measured by high-performance liquid chromatography. Vitreous concentrations of TA after intravitreal injection were 1.22 ± 0.24 μg/ml, significantly higher than those after subtenon injection (<0.001 μg/ml, P =. 003). Vitreous concentrations of TA after subtenon injection and TA-assisted vitrectomy performed in a few patients to visualize the transparent vitreous gel were 0.20 ± 0.11 μg/ml, an intermediate amount between these two groups. Much higher vitreous concentrations of TA after intravitreal injection than subtenon injection may accelerate therapeutic effect when intravitreal injections are given to reduce macular edema. Subtenon injections of TA may act via the sclera as opposed to the vitreous.

UR - http://www.scopus.com/inward/record.url?scp=11144253482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144253482&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2004.05.028

DO - 10.1016/j.ajo.2004.05.028

M3 - Article

C2 - 15629301

AN - SCOPUS:11144253482

VL - 138

SP - 1046

EP - 1048

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 6

ER -